SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Meet the rescue team behind the astronauts as Artemis II's launch approaches - 2Partake in the Outside: Senior-Accommodating Exercises for 2024
- 3From a new flagship space telescope to lunar exploration, global cooperation – and competition – will make 2026 an exciting year for space
- 4Hundreds show fascist salute at rally in Rome in annual ritual
- 5These 2 moon rovers used cameras and lasers to hunt for simulated water ice — and one looks like WALL-E
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
- Where is Santa right now? NORAD tracks his 2025 Christmas Eve flight.
- Telescope in Chile captures stunning new picture of a cosmic butterfly
- What to know about the "wild, wild West" of viral peptide claims
- Thousands of small fish defy gravity to climb Congo waterfall
- At least 171 measles cases confirmed in 9 states, CDC data shows
- Careful Living: Embracing the Current Second
- Fundamental Home Machines: An Easy to understand Determination Guide
- Don't fall for it: These common tourist scams in Rome are easy to avoid if you know what you're looking for
